Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe COPD”

534 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 534 results

Testing effectiveness (Phase 2)Study completedNCT00634413
What this trial is testing

Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Pulmagen Therapeutics 91
Testing effectiveness (Phase 2)Study completedNCT04039113
What this trial is testing

Tezepelumab COPD Exacerbation Study

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 337
Post-approval studies (Phase 4)Study completedNCT00527826
What this trial is testing

Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 214
Testing effectiveness (Phase 2)Study completedNCT01108913
What this trial is testing

Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Revotar Biopharmaceuticals AG 60
Large-scale testing (Phase 3)Study completedNCT01574651
What this trial is testing

The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 934
Not applicableStudy completedNCT00281242
What this trial is testing

Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic ObstructiveLung Diseases, Obstructive
University of Michigan 37
Not applicableLooking for participantsNCT07382258
What this trial is testing

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novlead Inc. 16
Testing effectiveness (Phase 2)Study completedNCT03276078
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
AstraZeneca 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07330310
What this trial is testing

Trial of JKN2401 Injection in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Joincare Pharmaceutical Group Industry Co., Ltd 888
Not applicableStudy completedNCT03205826
What this trial is testing

Chartis Collateral Ventilation Measurement: Conscious Sedation Versus General Anesthesia

Who this might be right for
Emphysema or COPD
University Medical Center Groningen 30
Testing effectiveness (Phase 2)Study completedNCT03645434
What this trial is testing

A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 73
Large-scale testing (Phase 3)Study completedNCT01462929
What this trial is testing

Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 414
Post-approval studies (Phase 4)Study completedNCT01966107
What this trial is testing

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.

Who this might be right for
COPDChronic Obstructive Pulmonary DiseaseModerate to Very Severe COPD
AstraZeneca 3,635
Not applicableStudy completedNCT03583203
What this trial is testing

Tobacco Intensive Motivational and Estimate Risk

Who this might be right for
Severe Mental DisorderSmoking CessationCOPD
Hospital Universitario Reina Sofia de Cordoba 230
Large-scale testing (Phase 3)Ended earlyNCT01155310
What this trial is testing

Efficacy of Helium/Oxygen Compared to Air/Oxygen in Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Air Liquide Santé International 446
Post-approval studies (Phase 4)Study completedNCT01480661
What this trial is testing

Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
FLUIDDA nv 41
Post-approval studies (Phase 4)Study completedNCT00115492
What this trial is testing

Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 797
Testing effectiveness (Phase 2)Looking for participantsNCT07082738
What this trial is testing

Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 1,160
Testing effectiveness (Phase 2)Study completedNCT00507949
What this trial is testing

Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight

Who this might be right for
Chronic Obstructive Pulmonary Disease
Rottapharm Spain 40
Post-approval studies (Phase 4)Study completedNCT02153489
What this trial is testing

A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 30
Load More Results